{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"imerslund-grasbeck-syndrome-type-2","columns":[{"gene":"","key":"population-d287f4e93dbb96e95634","label":"Imerslund-Grasbeck syndrome 2","mondoId":"MONDO:0100157","onsetQualifier":null,"originColumnKey":"MONDO:0100157/OMIM:618882","originalViews":[{"key":"MONDO:0100157/OMIM:618882","label":"Imerslund-Grasbeck syndrome 2","scopeLabel":"OMIM:618882","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["28e2b47b7f114ca9de150a099e2c22f6f9f8cf589dd926b4e0c00dd469538cf9","37d0f30a15700e7b6f4f8f4268e097905cc5852f81b10729cc2dece76c8a3275","5bc315fee4d44df64e9966b3c81109e2d279b78507ceb584986b93f5496b3eb3","68bb9425b872dfdf174ec185dfd96388fb82988e0cccd46700c73f5a26f622f3","919af309e625ed2f2a2b7819b27ecdd0de63f8d0884787b8ea950129313bc677","925ddc637818756f7ed798f2a6be216337123b1ad0d6b6ba78df5f71f440384d","c865ef74d453f467c7dbdbd2b5d7c4ec130a550528bf14ad9af93da77be1e1fe","e09cdca26a60b0d9419d7b01828324eaea981c94ad5e3a71f3a6528fad5299f3","f8324d588eb94bb09a9de9ecfb5278804a8a0e1964efda7e45b8078d90230dd1","ff971e7ac405a7fdc26c7f196bd9cb471ca79519e63837b249952f6bb265762a"],"recordQualifiers":{},"scopeLabel":"OMIM:618882","sourceIds":["OMIM:618882"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-d287f4e93dbb96e95634"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001903","HP:0100502","HP:0002014","HP:0001510","HP:0008454","HP:0001889","HP:0012594"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":10,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":10,"sourceGroups":{"published":10}},"features":[{"hpoId":"HP:0001903","label":"Anemia","primary":true},{"hpoId":"HP:0100502","label":"Decreased circulating vitamin B12 concentration","primary":true},{"hpoId":"HP:0002014","label":"Diarrhea","primary":true},{"hpoId":"HP:0001510","label":"Growth delay","primary":true},{"hpoId":"HP:0008454","label":"Lumbar kyphosis","primary":true},{"hpoId":"HP:0001889","label":"Megaloblastic anemia","primary":true},{"hpoId":"HP:0012594","label":"Moderate albuminuria","primary":true},{"hpoId":"HP:0000093","label":"Proteinuria","primary":false},{"hpoId":"HP:0000010","label":"Recurrent urinary tract infections","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false}],"ledeHtml":"An autosomal recessive disorder characterized by onset of megaloblastic anemia associated with decreased serum vitamin B12 (cobalamin, Cbl) in infancy or early childhood. Low molecular weight (LMW) proteinuria is frequently present, but usually occurs later and is usually mild or subclinical. Patients often present with vague symptoms, including failure to thrive, loss of appetite, fatigue, lethargy, and/or recurrent infections. Treatment with vitamin B12 results in sustained clinical improvement of the anemia. The proteinuria is nonprogressive, and affected individuals do not have deterioration of kidney function; correct diagnosis is important to prevent unnecessary treatment. The disorder results from a combination of vitamin B12 deficiency due to selective malabsorption of the vitamin, and impaired reabsorption of LMW proteins in the proximal renal tubule. These defects are caused by disruption of the AMN/CUBN complex that forms the &#x27;cubam&#x27; receptor responsible for intestinal uptake of B12/GIF (CBLIF).","mondoId":"MONDO:0100157","node":{"canonicalSlug":"imerslund-grasbeck-syndrome-type-2","comparisons":[{"documentSha256":"07dc730e129bc7961e3eb0b4dc3c777c03cedc7e079f0d5e363d3cbe012932af","key":"legacy-imerslund-grasbeck","kind":"legacy","label":"Imerslund-Grasbeck syndrome","memberIds":["MONDO:0009853","MONDO:0100156","MONDO:0100157"],"mondoId":"MONDO:0009853","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/imerslund-grasbeck.07dc730e129bc7961e3eb0b4dc3c777c03cedc7e079f0d5e363d3cbe012932af.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"Imerslund-Grasbeck syndrome type 2","paragraphs":["An autosomal recessive disorder characterized by onset of megaloblastic anemia associated with decreased serum vitamin B12 (cobalamin, Cbl) in infancy or early childhood. Low molecular weight (LMW) proteinuria is frequently present, but usually occurs later and is usually mild or subclinical. Patients often present with vague symptoms, including failure to thrive, loss of appetite, fatigue, lethargy, and/or recurrent infections. Treatment with vitamin B12 results in sustained clinical improvement of the anemia. The proteinuria is nonprogressive, and affected individuals do not have deterioration of kidney function; correct diagnosis is important to prevent unnecessary treatment. The disorder results from a combination of vitamin B12 deficiency due to selective malabsorption of the vitamin, and impaired reabsorption of LMW proteins in the proximal renal tubule. These defects are caused by disruption of the AMN/CUBN complex that forms the 'cubam' receptor responsible for intestinal uptake of B12/GIF (CBLIF)."],"scope":"exact","source":"MONDO","upstream":"OMIM:618882","url":"https://monarchinitiative.org/MONDO:0100157"},"ownColumnKeys":["population-d287f4e93dbb96e95634"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal recessive disease","mondoId":"MONDO:0006025","slug":null},{"kind":"parent","label":"Imerslund-Grasbeck syndrome","mondoId":"MONDO:0009853","slug":"imerslund-grasbeck"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26067"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"28e2b47b7f114ca9de150a099e2c22f6f9f8cf589dd926b4e0c00dd469538cf9","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"1/8","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"37d0f30a15700e7b6f4f8f4268e097905cc5852f81b10729cc2dece76c8a3275","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"8/8","hpo_id":"HP:0100502","is_excluded":false,"label":"Decreased circulating vitamin B12 concentration","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5bc315fee4d44df64e9966b3c81109e2d279b78507ceb584986b93f5496b3eb3","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"1/8","hpo_id":"HP:0000010","is_excluded":false,"label":"Recurrent urinary tract infections","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"68bb9425b872dfdf174ec185dfd96388fb82988e0cccd46700c73f5a26f622f3","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"2/8","hpo_id":"HP:0001889","is_excluded":false,"label":"Megaloblastic anemia","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"919af309e625ed2f2a2b7819b27ecdd0de63f8d0884787b8ea950129313bc677","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"5/8","hpo_id":"HP:0001903","is_excluded":false,"label":"Anemia","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"925ddc637818756f7ed798f2a6be216337123b1ad0d6b6ba78df5f71f440384d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"3/8","hpo_id":"HP:0012594","is_excluded":false,"label":"Moderate albuminuria","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c865ef74d453f467c7dbdbd2b5d7c4ec130a550528bf14ad9af93da77be1e1fe","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"7/8","hpo_id":"HP:0000093","is_excluded":false,"label":"Proteinuria","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e09cdca26a60b0d9419d7b01828324eaea981c94ad5e3a71f3a6528fad5299f3","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"0/8","hpo_id":"HP:0000083","is_excluded":true,"label":"Renal insufficiency","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f8324d588eb94bb09a9de9ecfb5278804a8a0e1964efda7e45b8078d90230dd1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"1/8","hpo_id":"HP:0008454","is_excluded":false,"label":"Lumbar kyphosis","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ff971e7ac405a7fdc26c7f196bd9cb471ca79519e63837b249952f6bb265762a","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:618882","disease_name":"Imerslund-Grasbeck syndrome 2","evidence":"PCS","frequency_raw":"2/8","hpo_id":"HP:0002014","is_excluded":false,"label":"Diarrhea","onset_id":null,"reference":"PMID:24156255","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100157\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>OMIM:618882</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An autosomal recessive disorder characterized by onset of megaloblastic anemia associated with decreased serum vitamin B12 (cobalamin, Cbl) in infancy or early childhood. Low molecular weight (LMW) proteinuria is frequently present, but usually occurs later and is usually mild or subclinical. Patients often present with vague symptoms, including failure to thrive, loss of appetite, fatigue, lethargy, and/or recurrent infections. Treatment with vitamin B12 results in sustained clinical improvement of the anemia. The proteinuria is nonprogressive, and affected individuals do not have deterioration of kidney function; correct diagnosis is important to prevent unnecessary treatment. The disorder results from a combination of vitamin B12 deficiency due to selective malabsorption of the vitamin, and impaired reabsorption of LMW proteins in the proximal renal tubule. These defects are caused by disruption of the AMN/CUBN complex that forms the &#x27;cubam&#x27; receptor responsible for intestinal uptake of B12/GIF (CBLIF).</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100157\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"imerslund-grasbeck-syndrome-type-2","sourceDocuments":[{"name":"MONDO: Imerslund-Grasbeck syndrome type 2","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0100157"}],"sourceNote":"","synonyms":["Imerslund-Grasbeck syndrome 2","megaloblastic anemia, Norwegian type"],"takeawayHtml":"","title":"Imerslund-Grasbeck syndrome type 2"},"schemaVersion":1}
